ArticleFrontiers in oncology2025

Artificial intelligence-based evaluation of prognostic benefits from immunotherapy plus targeted therapy with or without radiotherapy or TACE in advanced hepatocellular carcinoma.

Yuehong Deng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.